Herantis Pharma Oyj (HRTIS) - Total Liabilities

Latest as of June 2025: €3.36 Million EUR ≈ $3.93 Million USD

Based on the latest financial reports, Herantis Pharma Oyj (HRTIS) has total liabilities worth €3.36 Million EUR (≈ $3.93 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Herantis Pharma Oyj operating cash flow efficiency to assess how effectively this company generates cash.

Herantis Pharma Oyj - Total Liabilities Trend (2011–2024)

This chart illustrates how Herantis Pharma Oyj's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Herantis Pharma Oyj to evaluate the company's liquid asset resilience ratio.

Herantis Pharma Oyj Competitors by Total Liabilities

The table below lists competitors of Herantis Pharma Oyj ranked by their total liabilities.

Company	Country	Total Liabilities
HSS Engineers Bhd KLSE:0185	Malaysia	RM178.00 Million
HRS Co. Ltd KQ:036640	Korea	₩12.89 Billion
Tune Protect Group Bhd KLSE:5230	Malaysia	RM600.85 Million
Melhus Sparebank OL:MELG	Norway	Nkr10.35 Billion
Bright Sheland International Co Ltd TWO:4556	Taiwan	NT$767.27 Million
Cingulate Inc NASDAQ:CING	USA	$12.56 Million
Optivision Technology TWO:3666	Taiwan	NT$387.67 Million
Boreo Oyj HE:BOREO	Finland	€102.00 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Herantis Pharma Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Herantis Pharma Oyj market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.10	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.71	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.92	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.66	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Herantis Pharma Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Herantis Pharma Oyj (2011–2024)

The table below shows the annual total liabilities of Herantis Pharma Oyj from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	€2.81 Million ≈ $3.29 Million	+39.36%
2023-12-31	€2.02 Million ≈ $2.36 Million	-67.91%
2022-12-31	€6.29 Million ≈ $7.36 Million	-1.12%
2021-12-31	€6.36 Million ≈ $7.44 Million	-27.95%
2020-12-31	€8.83 Million ≈ $10.33 Million	-4.19%
2019-12-31	€9.22 Million ≈ $10.78 Million	+27.40%
2018-12-31	€7.24 Million ≈ $8.46 Million	-3.28%
2017-12-31	€7.48 Million ≈ $8.75 Million	-13.31%
2016-12-31	€8.63 Million ≈ $10.09 Million	+6.69%
2015-12-31	€8.09 Million ≈ $9.46 Million	+4.05%
2014-12-31	€7.77 Million ≈ $9.09 Million	+208.39%
2013-12-31	€2.52 Million ≈ $2.95 Million	+13.82%
2012-12-31	€2.21 Million ≈ $2.59 Million	+15.35%
2011-12-31	€1.92 Million ≈ $2.24 Million	--

About Herantis Pharma Oyj

HE:HRTIS Finland Biotechnology

Market Cap

$54.84 Million

€46.91 Million EUR

Market Cap Rank

#21646 Global

#108 in Finland

Share Price

€1.77

Change (1 day)

+1.14%

52-Week Range

€1.23 - €2.78

All Time High

€10.10